Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 101–200 of 721
Rheumatological complications of beta-thalassaemia: an overview
Noureldine, M. H. A., Taher, A. T., Haydar, A. A., Berjawi, A., Khamashta, M. A., & Uthman, I. W. (2017) · Rheumatology · doi:10.1093/rheumatology/kex058 · Cited by 33
High-resolution melting analysis for prenatal diagnosis of beta-thalassemia in northern Thailand
Charoenkwan, P., Sirichotiyakul, S., Phusua, A., Suanta, S., Fanhchaksai, K., Saetung, R., & Sanguansermsri, T. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2306-1 · Cited by 29
Long, J. D., Hoban, M. D., Cooper, A. R., Kaufman, M. L., Kuo, C. Y., Campo-Fernández, B., Lumaquin, D., Hollis, R. P., Wang, X., Kohn, D. B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.001 · Cited by 33
Prevalence of multiple sclerosis in Sardinia: A systematic cross-sectional multi-source survey
Urru, S. A. M., Antonelli, A., Sechi, G. M., & MS Working Group (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519828600 · Cited by 35
Interfacial energy driven distinctive pattern formation during the drying of blood droplets.
Mukhopadhyay, M., Ray, R., Ayushman, M., Sood, P., Bhattacharyya, M., Sarkar, D., & Dasgupta, S. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.04.008 · Cited by 23
CRISPR-Cas9 for treating hereditary diseases
Mani, I. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.017 · Cited by 41
Droplet‑based digital PCR for non‑invasive prenatal genetic diagnosis of α and β‑thalassemia
Sawakwongpra, K., Tangmansakulchai, K., Ngonsawan, W., Promwan, S., Chanchamroen, S., Quangkananurug, W., Sriswasdi, S., Jantarasaengaram, S., & Ponnikorn, S. (2021) · Biomedical Reports · doi:10.3892/br.2021.1458 · Cited by 30
Tang, C., Furnback, W. E., Wang, B. C. M., Tang, J., Tang, D. H., Lu, M., Huang, V. W. ‐., & Musallam, K. M. (2021) · Transfusion · doi:10.1111/trf.16636 · Cited by 31
Geographical distribution of β-globin gene mutations in Syria
Murad, H., Moasses, F., Dabboul, A., Mukhalalaty, Y., Bakoor, A. O., Al‐Achkar, W., & Jarjour, R. A. (2018) · Hematology · doi:10.1080/10245332.2018.1461291 · Cited by 29
Hydroxyurea for lifelong transfusion-dependent β-thalassemia: A meta-analysis
Algiraigri, A. H., Wright, N. A. M., Paolucci, E. O., & Kassam, A. (2017) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2017.1354948 · Cited by 30
Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients
Soltanpour, M. S., & Davari, K. (2015) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.172179 · Cited by 28
Craniofacial Characteristics of Thalassemia Major Patients
Karakaş, S., Tellioğlu, A. M., Bilgin, M., Ömürlü, İ. K., Çalışkan, S. Ö., & Coskun, S. (2017) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2016.150013 · Cited by 28
A new gene associated with a β-thalassemia phenotype: the observation of variants in SUPT5H
Achour, A., Koopmann, T. T., Castel, R., Santen, G. W. E., den Hollander, N. S., Knijnenburg, J., Ruivenkamp, C. A. L., Arkesteijn, S. G. J., ter Huurne, J., Bisoen, S., et al. (2020) · Blood · doi:10.1182/blood.2020005934 · Cited by 28
New strategies to target iron metabolism for the treatment of beta thalassemia
Oikonomidou, P. R., Casu, C., & Rivella, S. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13018 · Cited by 28
Islam, M. T., Sarkar, S. K., Sultana, N., Begum, M. N., Bhuyan, G. S., Talukder, S., Muraduzzaman, A. K. M., Alauddin, M., Islam, M. S., Biswas, P. P., et al. (2018) · BMC Genetics · doi:10.1186/s12863-017-0594-3 · Cited by 30
Common host variation drives malaria parasite fitness in healthy human red cells
Ebel, E. R., Kuypers, F. A., Lin, C., Petrov, D. A., & Egan, E. S. (2021) · eLife · doi:10.7554/elife.69808 · Cited by 36
Huang, R., Liu, Y., Xu, J., Lin, D., Mao, A., Yang, L., Zhong, G., Wang, H., Xu, R., Chen, Y., et al. (2023) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0168-oa · Cited by 28
Amato, A., Cappabianca, M. P., Lerone, M., Colosimo, A., Grisanti, P., Ponzini, D., Biagio, P. D., Perri, M., Gianni, D., Rinaldi, S., et al. (2013) · Journal of Community Genetics · doi:10.1007/s12687-013-0171-z · Cited by 26
Laboratory tests for coagulation system monitoring in a patient with β-thalassemia
Seregina, E. A., Nikulina, O. F., Tsvetaeva, N. V., Rodionova, M. N., Грибкова, И. В., Борисовна, О. Е., Zapariy, A. P., Erasov, A. V., Balandina, A. N., Ananyeva, N. M., et al. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1559-1 · Cited by 28
Splenectomy for patients with β-thalassemia major: long-term outcomes
Ammar, S. A., Elsayh, K. I., Embaby, M. M., & Zahran, A. M. (2014) · The Egyptian Journal of Surgery · doi:10.4103/1110-1121.147614 · Cited by 25
Splenectomy for people with thalassaemia major or intermedia
Sharma, A., Mathew, M. E., & Puri, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010517.pub3 · Cited by 28
Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area
Qari, M. H., Wali, Y. A. M. S., Albagshi, M. H., Alshahrani, M. H., Alzahrani, A., Hijji, I. A., Al-Momen, A., Al‐Jefri, A., Saeed, H. H. A., Abdullah, S., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-143 · Cited by 25
Haemoglobinopathies and the rheumatologist
Hughes, M., Akram, Q., Rees, D. C., & Jones, A. K. P. (2016) · Rheumatology · doi:10.1093/rheumatology/kew042 · Cited by 26
Kittivorapart, J., Crew, V. K., Wilson, M. C., Heesom, K. J., Siritanaratkul, N., & Toye, A. M. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017011726 · Cited by 25
Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT)
Al-Amodi, A. M., Ghanem, N. Z., Aldakeel, S. A., Asoom, L. I. A., Rafique, N., Almandil, N. B., Naserullah, Z. A., Al‐Jarrash, S., Akhtar, M., AbdulAzeez, S., et al. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1435520 · Cited by 34
Embryo and fetal gene editing: Technical challenges and progress toward clinical applications
Mattar, C. N. Z., Chew, W. L., & Lai, P. S. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101229 · Cited by 26
Hematological Parameters in Individuals with Beta Thalassemia Trait in South Sumatra, Indonesia
Sari, D. P., Wahidiyat, P. A., Setianingsih, I., Timan, I. S., Gatot, D., & Kekalih, A. (2022) · Anemia · doi:10.1155/2022/3572986 · Cited by 24
He, B., Zhan, Y., Cai, C., Yu, D.-Y., Wei, Q., Quan, L.-P., Huang, D., Liu, Y., Li, Z., Liu, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1030976 · Cited by 24
Sun, K., Huang, Y., Palanisamy, K., Chang, S., Wang, I., Wu, K., Chen, P., Peng, C., & Li, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00150-7 · Cited by 26
Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies
Heydarian, S., Jafari, R., Dailami, K. N., Hashemi, H., Jafarzadehpour, E., Heirani, M., Yekta, A., Mahjoob, M., & Khabazkhoob, M. (2019) · International Ophthalmology · doi:10.1007/s10792-019-01189-3 · Cited by 29
Ansharullah, B. A., Sutanto, H., & Romadhon, P. Z. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102911 · Cited by 26
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
Frangoul, H., Hanna, R., Walters, M. C., Kao, R. L., Carroll, C., McManus, M. P., Chang, K., Jaskolka, M. C., Kim, K., Yu, Q., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2501277 · Cited by 23
Sriwichaiin, S., Thiennimitr, P., Thonusin, C., Sarichai, P., Buddhasiri, S., Kumfu, S., Nawara, W., Kittichotirat, W., Fucharoen, S., Chattipakorn, N., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120871 · Cited by 26
Gene modification therapies for hereditary diseases in the fetus
Mattar, C. N. Z., Chan, J. K. Y., & Choolani, M. A. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6347 · Cited by 28
Haghpanah, S., Esmaeilzadeh, M., Honar, N., Hassani, F., Dehbozorgian, J., Rezaei, N., Abdollahi, M., Bardestani, M., Safaei, S., & Karimi, M. (2015) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.17(5)2015.28343 · Cited by 30
Izumikawa, K., Yoshikawa, H., Ishikawa, H., Nobe, Y., Yamauchi, Y., Philipsen, S., Simpson, R. J., Isobe, T., & Takahashi, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw831 · Cited by 23
he, S. T., Wei, Y., Li, L., Chen, Q., Yi, S., Zuo, Y., Wei, H., Zheng, C., Chen, B., & Qiu, X. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22304 · Cited by 23
Beyond Mendelian Inheritance: Genetic Buffering and Phenotype Variability
Rossi, A., & Kontarakis, Z. (2021) · Phenomics · doi:10.1007/s43657-021-00030-1 · Cited by 27
Alternative options for DNA-based experimental therapy of β-thalassemia
Gambari, R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.665047 · Cited by 30
Venkatesan, V., Srinivasan, S., Babu, P., & Thangavel, S. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-20 · Cited by 26
Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form
Geißler, S., Hellwig, M., Markwárdt, F., Henle, T., & Brandsch, M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.032 · Cited by 21
Barrett, K. M. S., Bolze, A., Ni, Y., White, S. J., Isaksson, M., Sharma, L., Levin, E., Lee, W., Grzymski, J. J., Lu, J. T., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01293-9 · Cited by 21
Identification of rare thalassemia variants using third-generation sequencing
Liu, Q., Chen, Q., Zhang, Z., Peng, S., Liu, J., Pang, J., Jia, Z., Xi, H., Li, J., Chen, L., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1076035 · Cited by 21
Jha, R., & Jha, S. K. (2014) · Journal of Pathology of Nepal · doi:10.3126/jpn.v4i8.11609 · Cited by 21
Bianchi, N., Cosenza, L. C., Lampronti, I., Finotti, A., Breveglieri, G., Zuccato, C., Fabbri, E., Marzaro, G., Chilin, A., Angelis, G. D., et al. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0187-2 · Cited by 21
Epigenetic effects toward new insights as potential therapeutic target in B-thalassemia
Eltaweel, N. H., El‐Kamah, G. Y., Khairat, R., Atia, H. A., & Amr, K. S. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00138-x · Cited by 25
Splenectomy for people with thalassaemia major or intermedia
Mathew, M. E., Sharma, A., & Aravindakshan, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010517.pub2 · Cited by 22
Modarres, M., Shariati, L., Hejazi, Z., Shahbazi, M., Tabatabaiefar, M. A., & Khanahmad, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26412 · Cited by 24
Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review
Locke, M., Reddy, P. S., & Badawy, S. M. (2022) · Hemoglobin · doi:10.1080/03630269.2022.2072320 · Cited by 24
Sistani Population: a Different Spectrum oF β-Thalassemia Mutations From other Ethnic Groups of Iran
Miri‐Moghaddam, E., Zadeh–Vakili, A., Nikravesh, A., Sistani, S. S., & Narooie-Nejad, M. (2013) · Hemoglobin · doi:10.3109/03630269.2013.769886 · Cited by 20
Nonsense mediated RNA decay and evolutionary capacitance
Raxwal, V. K., & Říha, K. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.09.001 · Cited by 20
Emerging strategies of blood group genotyping for patients with hemoglobinopathies
Belsito, A., Magnussen, K., & Napoli, C. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.11.007 · Cited by 24
Quality of life among adolescents aged 14 to 18 years with Beta-Thalassemia Major (TM) in Qatar.
Nashwan, A. J., Yassin, M. A., Babu, G. D. J., Nair, S. K., Libo-on, I. L. M., Hijazi, H., Sanctis, V. D., & Soliman, A. T. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i2-s.7083 · Cited by 20
Dheyab, H. F., Uçan, O. N., Khalaf, M., & Mohammed, A. H. (2020) · International Symposium on Multidisciplinary Studies and Innovative Technologies (ISMSIT) · doi:10.1109/ismsit50672.2020.9254994 · Cited by 20
Spitalieri, P., Talarico, R. V., Botta, A., Murdocca, M., D’Apice, M. R., Orlandi, A., Giardina, E., Santoro, M., Brancati, F., Novelli, G., et al. (2015) · Cellular Reprogramming · doi:10.1089/cell.2015.0003 · Cited by 19
Чадаева, И. В., Пономаренко, П. М., Рассказов, Д. А., Sharypova, E. B., Kashina, E. V., Zhechev, D. A., Drachkova, I. A., Arkova, O. V., Savinkova, L. K., Ponomarenko, M. P., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4478-3 · Cited by 19
Aldakeel, S. A., Ghanem, N. Z., Al-Amodi, A. M., Osman, A. K., Asoom, L. I. A., Rafique, N., Almandil, N. B., Akhtar, M., AbdulAzeez, S., & Borgio, J. F. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.84825 · Cited by 19
Tamaddoni, A., Nasseri, E., Mohammadi, E., Qujeq, D., Zayeri, F., Zand, H., Mir, S. M., & Gholami, M. (2019) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2019.100324 · Cited by 20
A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients
Soltani, S., Zakeri, A., Tabibzadeh, A., Zandi, M., Ershadi, E., Rezayat, S. A., Khaseb, S., Zakeri, A. M., Nakhaei, M. A., Afzali, S., et al. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00284-x · Cited by 20
Gene therapy for β-thalassemia: current and future options
Hardouin, G., Miccio, A., & Brusson, M. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.12.001 · Cited by 23
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia
Breda, L., Rivella, S., Zuccato, C., & Gambari, R. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.24 · Cited by 22
Cappellini, M. D., Porter, J. B., Musallam, K. M., Kattamis, A., Viprakasit, V., Galanello, R., & Taher, A. T. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.10.003 · Cited by 20
Self-citationBreveglieri, G., D’Aversa, E., Gallo, T. E., Pellegatti, P., Guerra, G., Cosenza, L. C., Finotti, A., Gambari, R., & Borgatti, M. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.12.209 · Cited by 19
Şahin, A., Er, E. Ö., Öz, E., Yıldırmak, Z. Y., & Bakırdere, S. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02217-5 · Cited by 23
Volloch, V., Rits‐Volloch, S., & Olsen, B. R. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.01-1003 · Cited by 20
CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review
Khiabani, A., Kohansal, M. H., Keshavarzi, A., Shahraki, H., Kooshesh, M., Karimzade, M., & Navashenaq, J. G. (2022) · Molecular Genetics and Genomics · doi:10.1007/s00438-022-01978-z · Cited by 20
Thongchote, K., Svasti, S., Teerapornpuntakit, J., Krishnamra, N., & Charoenphandhu, N. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2014 · Cited by 18
Fettah, A., Bayram, C., Yaralı, N., Işık, P., Kara, A., Çulha, V., & Tunç, B. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.055 · Cited by 18
Raz, S., Koren, A., Dan, O., & Levin, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13103 · Cited by 19
Moradabadi, A., Farsinejad, A., Khansarinejad, B., & Fatemi, A. (2019) · Experimental Hematology and Oncology · doi:10.1186/s40164-019-0134-0 · Cited by 18
Abnormal regulation of microRNAs and related genes in pediatric β‐thalassemia
Wang, H., Chen, M., Xu, S., Pan, Y., Zhang, Y., Huang, H., & Xu, L. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23945 · Cited by 28
Ocular refractive and biometric characteristics in patients with thalassaemia major
Nowroozzadeh, M. H., Kalantari, Z., Namvar, K., & Meshkibaf, M. H. (2011) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2010.00579.x · Cited by 18
Pepe, A., Rossi, G., Bentley, A., Putti, M. C., Frizziero, L., D’Ascola, D. G., Cuccia, L., Spasiano, A., Filosa, A., Caruso, V., et al. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0496-1 · Cited by 18
Phenotype of mutations in the promoter region of the β-globin gene
Ropero, P., Erquiaga, S., Arrizabalaga, B., Pérez, G., de la Iglesia, S., Torrejón, M. J., Gil, C., Elena, C., Tenorio, M., Nieto, J. M., et al. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204378 · Cited by 18
Clinical application of base editing for treating β-thalassaemia
Lai, Y., Liu, R., Wang, L., Ma, X.-K., Li, Y., Yang, G., Shi, L., Guo, Y., Wei, Z., Zhou, X., et al. (2026) · Nature · doi:10.1038/s41586-026-10342-9 · Cited by 22
Alayoubi, A. M., Khawaji, Z. Y., Mohammed, M. A., & Mercier, F. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05457-2 · Cited by 27
Telfer, T. J., Richardson‐Sanchez, T., Gotsbacher, M. P., Nolan, K. P., Tieu, W., & Codd, R. (2019) · BioMetals · doi:10.1007/s10534-019-00175-7 · Cited by 17
Ulusoy, M. O., Türk, H., & Kıvanç, S. A. (2019) · Journal of Current Ophthalmology · doi:10.1016/j.joco.2019.01.012 · Cited by 17
Thalassemia: Common Clinical Queries in Management
Lal, A., & Bansal, D. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-019-03065-5 · Cited by 17
Gravia, A., Chondrou, V., Κολλιοπούλου, Α., Kourakli, A., John, A., Symeonidis, A. S., Ali, B. R., Sgourou, A., Papachatzopoulou, A., Κάτσιλα, Θ., et al. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0076 · Cited by 21
Mutation analysis of β-thalassemia in East-Western Indian population: a recent molecular approach
Shah, P. S., Shah, N. D., Ray, H. S. P., Khatri, N. B., Vaghasia, K. K., Raval, R. J., Shah, S. C., & Rao, M. V. (2017) · The Application of Clinical Genetics · doi:10.2147/tacg.s127531 · Cited by 18
Telfer, T. J., & Codd, R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00340 · Cited by 17
Devanesan, S., AlQahtani, F. S., Alsalhi, M. S., Karuppaiah, J., & Masilamani, V. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.02.018 · Cited by 17
Fracture prevalence in thalassemia: a systematic review and meta-analysis
Charoenngam, N., Rittiphairoj, T., & Ponvilawan, B. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01026-0 · Cited by 16
Analytical evaluation of the C apillarys 2 F lex piercing for routine haemoglobinopathies diagnosis
Agouti, I., Merono, F., Bonello‐Palot, N., & Badens, C. (2012) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12000 · Cited by 16
Treating hemoglobinopathies using gene-correction approaches: promises and challenges
Cottle, R. N., Lee, C. M., & Bao, G. (2016) · Human Genetics · doi:10.1007/s00439-016-1696-0 · Cited by 20
Probability of change in life: Amino acid changes in single nucleotide substitutions
Chan, K.-F., Koukouravas, S., Yeo, J. Y., Koh, D. W., & Gan, S. K. (2020) · Biosystems · doi:10.1016/j.biosystems.2020.104135 · Cited by 16
Noninvasive prenatal diagnosis for pregnancies at risk for β‐thalassaemia: a retrospective study
Lv, W., Linpeng, S., Li, Z., Liang, D., Jia, Z., Meng, D., Cram, D., Zhu, H., Teng, Y., Yin, A., et al. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16295 · Cited by 18
Zhao, Y., Jiang, F., & Li, D. (2020) · Hemoglobin · doi:10.1080/03630269.2020.1793774 · Cited by 16
Beta-thalassemia in Mediterranean countries. Findings and outlook
Bellis, G., & Parant, A. (2021) · Investigaciones Geográficas · doi:10.14198/ingeo.19079 · Cited by 16
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
Caocci, G., Nasa, G. L., d’Aloja, E., Vacca, A., Piras, E., Pintor, M., Demontis, R., & Pisu, S. (2011) · BMC Medical Ethics · doi:10.1186/1472-6939-12-4 · Cited by 16
Changes in lncRNAs and related genes in β-thalassemia minor and β-thalassemia major
Ma, J., Liu, F., Du, X., Ma, D., & Xiong, L. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0503-1 · Cited by 21
Breveglieri, G., Bianchi, N., Cosenza, L. C., Gamberini, M. R., Chiavilli, F., Zuccato, C., Montagner, G., Borgatti, M., Lampronti, I., Finotti, A., et al. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0450-3 · Cited by 17
Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major
Thanuthanakhun, N., Nuntakarn, L., Sampattavanich, S., Anurathapan, U., Phuphanitcharoenkun, S., Pornpaiboonstid, S., Borwornpinyo, S., & Hongeng, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187610 · Cited by 16
Kubikova, N., Babariya, D., Sarasa, J., Spath, K., Alfarawati, S., & Wells, D. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.05.005 · Cited by 16
Budna, J., Światły‐Błaszkiewicz, A., Celichowski, P., Kałużna, S., Konwerska, A., Sujka‐Kordowska, P., Jankowski, M., Kulus, M., Ješeta, M., Piotrowska‐Kempisty, H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143387 · Cited by 18
Alnaami, A., & Wazqar, D. Y. (2019) · Pielegniarstwo XXI wieku / Nursing in the 21st Century · doi:10.2478/pielxxiw-2019-0014 · Cited by 15
Genetics of cerebral malaria: pathogenesis, biomarkers and emerging therapeutic interventions
Nortey, L. N., Anning, A. S., Nakotey, G. K., Ussif, A. M., Opoku, Y. K., Osei, S. A., Aboagye, B., & Ghartey‐Kwansah, G. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00830-6 · Cited by 21
Autoimmune Hemolytic Anemia in Patients with β-Thalassemia Major
Xu, L., Fang, J., Weng, W., Huang, K., & Zhang, Y. (2012) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2012.666782 · Cited by 15
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.